(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
Non-Hodgkin's Lymphoma
A dose ranging trial for pixantrone in the FND-R variant regimen in indolent Non-Hodgkin's Lymphoma (NHL). Volunteers who are 18 years or older and have a diagnosis of relapsed or refractory indolent (low-grade) NHL, may be eligible to participate. Research sites located throughout the United States.
More Information
Please see http://www.centerwatch.com/patient/studies/cat203.html.
-----
Liver Disease
A research study in patients who have liver disease and high cholesterol. Volunteers who are at least 18 years old and have at least a 6 month history of liver disease may be eligible. Research sites located throughout the United States.
More Information
Please see http://www.centerwatch.com/patient/studies/cat93.html.
-----
Vaccines
A study of the safety, immunogenicity and consistency of three vaccines when given as a booster dose to healthy adolescents. Males and females between the ages of 10 and 18 may be eligible to participate. Research site located in Bronx, New York.
More Information
Please see http://www.centerwatch.com/patient/studies/cat372.html.
-----
Copyright 2003 CenterWatch. All rights reserved.
